Literature DB >> 10874489

Identification of cancer antigens: impact on development of cancer immunotherapies.

S A Rosenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10874489

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  3 in total

1.  Identification of endogenous HLA-A2-restricted reactivity against shared melanoma antigens in patients using the quantitative real-time polymerase chain reaction.

Authors:  Stacy E Thurber; Hung T Khong; Udai S Kammula; Steven A Rosenberg
Journal:  J Immunother       Date:  2002 Jan-Feb       Impact factor: 4.456

2.  Processing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes.

Authors:  X F Yang; D Mirkovic; S Zhang; Q E Zhang; Y Yan; Z Xiong; F Yang; I H Chen; L Li; H Wang
Journal:  Int J Immunopathol Pharmacol       Date:  2006 Oct-Dec       Impact factor: 3.219

Review 3.  Therapeutic vaccination with tumor cells that engage CD137.

Authors:  Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  J Mol Med (Berl)       Date:  2003-02-08       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.